Oct 31, 2014
After developments and tests since 2007, Terumo has now applied for the manufacture and marketing of skeletal myoblast sheets for the treatment of ischemic heart disease. Muscle tissue from the thigh of a patient is collected, and tissue is cultured in vitro to sheets...
Oct 31, 2014
The center will focus on the development of solid-state NMR and develop 1.2 – 1.3 GHz NMR equipment using high-temperature superconducting magnets. Liquid Helium consumption will be strongly reduced, and a 4D Super Multimodal imaging technology will be developed,...
Oct 30, 2014
J-TEC, in which Fujifilm had a 41 % stake since 2010, produces various regenerative medicine products such as myoblast sheets and regenerated liver tissue, with proprietary scaffolding methods. J-TEC has also developed a recombinant collagen produced in microorganisms...
Oct 30, 2014
The key product is Y-27632, a selective and potent ROCK inhibitor (ROCK: Rho-associated, coiled-coil containing protein kinase) acting on the ROCK signaling system. It was developed by Mitsubishi Tanabe Pharma and distributed by API corporation. In human ES cells, it...
Oct 30, 2014
In collaboration with CiRA, Kyoto University, the National Institute of Health Sciences and with funding from NEDO, Takara is developing commercial mass production of myocardial cells generated from iPS cells, for use in the clinical testing of cardiac toxicity...
